Molecular structures provide roadmap for targeted Parkinson's disease therapeutics. Researchers at Weill Cornell Medicine have uncovered how a key Parkinson's protein called LRRK2 shifts between inactive and active forms, revealing the structural changes that enable certain mutations to push the protein into an overactive state.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: Researchers at Weill Cornell Medicine have uncovered how a key Parkinson's protein called LRRK2 shifts between inactive and active forms, revealing the structural changes that enable certain mutations to push the protein into an overactive state. Mutations that cause LRRK2 to become abnormally active are among the most common genetic causes of Parkinson's disease.
- Ponto de atenção: molecular.
- Ponto de atenção: structures.
- Ponto de atenção: provide.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
:quality(85)/fe419b32-0397-4dd0-a9bf-efb30399c0ff.png)
